TNFSF10 and neoplasm: For example, ADSCs and MSCs could be modified to express anticancer molecules such as interferon (IFN)-β or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or express prodrug-converting enzymes in the tumor site.